Skip to content

Article: Cockayne Syndrome Proteins Maintain Mitochondrial Health Through NAD+ Signaling: Preclinical Findings

Cockayne Syndrome Proteins Maintain Mitochondrial Health Through NAD+ Signaling: Preclinical Findings


Synopsis

Cockayne syndrome (CS) is a rare premature aging disorder involving DNA repair defects and mitochondrial dysfunction. Across human, mouse, and nematode models, mitochondrial dysfunction was a consistent feature. NAD+ supplementation improved lifespan and healthspan in nematode models, and NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) corrected mitochondrial issues in CS patient cells. The findings link DNA damage, mitochondrial dysfunction, and poor cellular cleanup processes (mitophagy/autophagy) as drivers of accelerated aging in CS—issues that can be partly reversed by restoring NAD+.

Journal

Aging Cell

Read more

Metabolic Health

Combination of Metabolic Cofactors and Nicotinamide Riboside Reduces Obesity and Insulin Resistance: Preclinical Findings

SynopsisObesity is a global health problem marked by excessive fat that often leads to metabolic issues like insulin resistance, high blood pressure, abnormal cholesterol levels, and metabolic synd...

Read more
Neurological Health

Changes in NMN/NAD+ Ratio Activates SARM1 to Trigger Nerve Damage: Preclinical Findings

SynopsisAxon degeneration is a key feature of many neurodegenerative diseases. SARM1 is an enzyme that breaks down NAD+ and, when activated, causes axon destruction. The enzyme NMNAT2 normally conv...

Read more